Contact
    Start Publications Poly (dimethyl diallyl ammonium chloride) incorporated ...
    ←  Publication Finder
    Attension

    Poly (dimethyl diallyl ammonium chloride) incorporated multilayer coating on biodegradable AZ31 magnesium alloy with enhanced resistance to chloride corrosion and promoted endothelialization

    Year: 2021

    Journal: Chem. Eng. J., Volume 421, OCT 1

    Authors: Zhang, Bo; Yao, Ruijuan; Maitz, Manfred F.; Mao, Genwen; Hou, Zhe; Yu, Hongchi; Luo, Rifang; Wang, Yunbing

    Organizations: National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51703144, 11802190]; Schoolenterprise cooperation projects [18H0088]; 111 Project (The Program of Introducing Talents of Discipline to Universities) [B16033]

    Keywords: Biodegradable cardiovascular stents; Chloride corrosion resistance; Biocompatible; Endothelialization; Green tea polyphenol chemistry; Layer-by-layer technology

    Controlled corrosion and proper biological response are key demands for biodegradable Mg-alloy based vascular stents. To achieve those properties, herein, a chemical conversion coating was fabricated through layer-by-layer (LBL) assembly via the sequential assembly of poly (dimethyl-diallyl ammonium chloride) (PDDA), epigallocatechin gallate (EGCG) and heparin (Hep). Each component in the coating played a unique role, in which EGCG chelates Mg ions and enhances the stability of the coating by introducing multiple intermolecular interactions, while PDDA effectively enhances the resistance against chloride corrosion, and Hep provides adequate hemocompatibility and promotes endothelialization. Electrochemical assay and immersion test demonstrated that the synergistic combination of PDDA and EGCG effectively suppressed the corrosion rate. A systematic in vitro and ex-vivo evaluation demonstrated an impressive antithrombotic performance, along with a selective promotion of endothelial cells (ECs) proliferation and inhibition of smooth muscle cells (SMCs) growth and macrophages (MAs) activation. More importantly, subcutaneous implantation and implantation in the abdominal aorta wall indicated that the PDDA/EGCG/Hep-modified implants displayed good corrosion resistance and mild tissue response, enhanced endothelialization and suppressed intima hyperplasia. These promising outcomes revealed the clinical potential of the PDDA/EGCG/Hep coating on AZ31 as biodegradable cardiovascular implants.
    View publication